Akèy › Maladi Crohn › Illinois › Waukegan

Etid klinik pou Maladi Crohn nan Waukegan, IL

5 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Waukegan (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2

Illinois Gastroenterology Group /ID# 283933, Gurnee · 3 mi lwen

Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07697456

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3

GI ALLIANCE - GURNEE ( Site 5003), Gurnee · 3 mi lwen

Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3

GI Alliance - Gurnee-Site Number: 8400049, Gurnee · 3 mi lwen

Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3

Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049, Gurnee · 3 mi lwen

Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2

Mirador Therapeutics Selected Site, Gurnee · 3 mi lwen

Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Maladi Crohn nan lòt vil

Lòt etid nan Waukegan

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.